A Call for Physiopathological Ethics

Por Lowenstein, Pedro R
Publicado em 2008

With a Little Help From My f(X)riends!: The Basis of Ad5-Mediated Transduction of the Liver Revealed

Por Lowenstein, Pedro R
Publicado em 2008

Clinical trials in gene therapy: Ethics of informed consent and the future of experimental medicine

Por Lowenstein, Pedro R
Publicado em 2008

Crossing the Rubicon

Por Lowenstein, Pedro R
Publicado em 2009

Risk in Clinical Research: Size Matters!

Por Lowenstein, Pedro R
Publicado em 2009

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado em 2009

The Value of EGFRvIII as the Target for Glioma Vaccines

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado no Am Soc Clin Oncol Educ Book (2014)

Gene Therapy Continues to Make Progress: Clinical and Regulatory Perspectives

Por Castro, Maria G., Lowenstein, Pedro R.
Publicado no Curr Gene Ther (2009)

Glioma trials and viral tribulations: can anything be concluded from non-controlled trials?

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado no J Neurol Neurosurg Psychiatry (2014)

The Long and Winding Road: from the high affinity choline uptake site to clinical trials for malignant brain tumors

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado no Adv Pharmacol (2016)

Multiple expressed endogenous glioma epitopes as novel vaccines for gliomas

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado no Clin Cancer Res (2016)

Evolutionary basis of a new approach for the treatment of malignant brain tumors: from mice to humans

Por Lowenstein, Pedro R., Castro, Maria G.
Publicado no Clin Immunol (2017)

Immunology of neurological gene therapy: How T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses

Por Lowenstein, Pedro R., Kroeger, Kurt, Castro, Maria G.
Publicado em 2007

ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability

Por Koschmann, Carl, Lowenstein, Pedro R., Castro, Maria G.
Publicado no Mol Cell Oncol (2016)

Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors

Por Pariente, Nonia, Sierra, Saleta, Lowenstein, Pedro R., Domingo, Esteban
Publicado em 2001

Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity

Por Sierra, Saleta, Dávila, Mercedes, Lowenstein, Pedro R., Domingo, Esteban
Publicado em 2000

Challenges in the evaluation, consent, ethics and history of early clinical trials – Implications of the Tuskegee ‘trial’ for safer and more ethical clinical trials

Por Lowenstein, Pedro R, Lowenstein, Elijah D, Castro, Maria G
Publicado em 2009

AAV6-Mediated Gene Silencing fALS Short

Por Mandel, Ronald J, Lowenstein, Pedro R, Byrne, Barry J
Publicado em 2011

Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy

Por Lowenstein, Pedro R, Baker, Gregory J, Castro, Maria G
Publicado no Oncoimmunology (2014)

Blocking Immunosuppressive Checkpoints for Glioma Therapy: The More the Merrier!

Por Castro, Maria G., Baker, Gregory J., Lowenstein, Pedro R.
Publicado no Clin Cancer Res (2014)